OraSure TechnologiesOSUR
OSUR
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
11% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 27
1% more funds holding
Funds holding: 187 [Q3] → 188 (+1) [Q4]
0.28% less ownership
Funds ownership: 90.2% [Q3] → 89.92% (-0.28%) [Q4]
8% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 63
16% less capital invested
Capital invested by funds: $287M [Q3] → $242M (-$45.1M) [Q4]
40% less call options, than puts
Call options by funds: $24K | Put options by funds: $40K
Research analyst outlook
We haven’t received any recent analyst ratings for OSUR.
Financial journalist opinion
Neutral
GlobeNewsWire
1 week ago
OraSure Announces $40 Million Stock Repurchase Program
BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors has authorized the repurchase of up to $40 million of its common stock over the next twenty-four months, which will be funded from cash on hand.

Neutral
Seeking Alpha
1 month ago
OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President & Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Casey Woodring - JPMorgan Andrew Cooper - Raymond James Operator Welcome to the OraSure Technologies, Inc. 2024 Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Negative
Zacks Investment Research
1 month ago
OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates
OraSure Technologies (OSUR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.22 per share a year ago.

Neutral
GlobeNewsWire
1 month ago
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025.

Positive
Zacks Investment Research
2 months ago
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?
OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 27th
ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.

Positive
Zacks Investment Research
2 months ago
Should Value Investors Buy OraSure Technologies (OSUR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 16th
MRCY, BBCP, OSUR, VIK and IFS have been added to the Zacks Rank #1 (Strong Buy) List on January 16, 2025.

Neutral
Business Wire
2 months ago
NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, filed a claim on Jan. 13 against OraSure Technologies (OraSure), asserting breach of contract, theft of a non-public device, misappropriation of trade secrets, unfair competition, and other violations of state and federal law for damages in federal court in the Eastern District of Pennsylvania. NOWDx is seeking compensatory and punitive damages.

Neutral
GlobeNewsWire
2 months ago
OraSure to Present at the J.P Morgan Healthcare Conference
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate in the 43rd Annual J.P. Morgan Healthcare Conference. OraSure's presentation is scheduled for Thursday, January 16, 2025 at 9:00 a.m. PT.

Charts implemented using Lightweight Charts™